Access the Full Abstract Book
Total Page:16
File Type:pdf, Size:1020Kb
Welcome from the Director Ravi Bhatia, M.D. Interim Director, O’Neal Comprehensive Cancer Center at UAB Professor of Medicine, Director, Division of Hematology/Oncology Martha Ann and David L. May Chair in Cancer Research I welcome each of you to the O’Neal Comprehensive Cancer Center’s 21st Annual Research Retreat. We are honored to have three keynote speakers who will focus on major paradigm shifts in our understanding of tumor progression. Our first keynote speaker, Dr. Dimitry Gabrivilovich, will describe recent advances in understanding how the immune response is attenuated by Myeloid Derived-Suppressor cells, which migrate into the tumor microenvironment and promote cancer progression. Our second keynote address by Dr. David Solit will focus on how the power of genomics can be harnessed by identifying those genes and pathways that can be therapeutically targeted in each cancer patient. Finally, our third keynote speaker, Dr. Stephen Schoenberger, will describe how novel proteins, or neoantigens, expressed on cancer cells, can be used to create personalized cancer vaccines and cellular immunotherapies. We are also happy to welcome the many new cancer researchers recently recruited to UAB and have invited six of them to speak at this Retreat. This event truly represents the stellar quality of cancer research being conducted here on a variety of levels. This year, we hit a record number in attendance and in abstract submissions. We also have the largest turnout of guests from neighboring institutions and organizations. We hope that our Retreat will continue to grow and bring together scientists from across the Southeast to exchange ideas and forge collaborations. Finally, I want to extend my thanks to Drs. Troy Randall and Soory Varambally and our wonderful staff for putting together this excellent program. 1 Acknowledgements Program Committee Troy Randall, Ph.D. Co-Chair Professor, Division of Immunology/Rheumatology Sooryanarayana Varambally, Ph.D. Co-Chair Associate Professor, Department Molecular and Cellular Pathology Statisticians Shaonin Ji, Ph.D. UAB Division of Preventive Medicine Liang Shan, Ph.D. UAB Division of Preventive Medicine Cover Image Getty Images, UAB Health System Marketing Event Planning and Assistance Mike Bertram Ryan Chambers Alan Cook Cindy Costes Brenda Evans Laura Gallitz Hilary Murrell Wesley Pate Meredith Preuss Courtney Ravenfeld Lisa Roth Susan Ruppert Danya Segrest Beena Thannickal Curran Umphrey 2 Research Competition Judges Farrukh Afaq Mythreye Karthikeyan Stephen Aller Michael Kase Rusty Arnold Kimberly Keene T. Prescott Atkinson Eugenia Kharlampieva Sejong Bae Young-Il Kim Scott Ballinger Christopher Klug Sanjib Banerjee Helen Krontiras Anju Bansal Matthew Kutny Luciana Barnes Laura Lambert Monica Baskin Rachael Lancaster Rajatava Basu Wendy Landier Olga Beliaeva Ben Larimer Susan Bellis Brittany Lasseigne Kirby Bland Jianmei Leavenworth Mark Bolding Margaret Xiaoguang Liu Rebecca Boohaker Runhua Liu Karim Budhwani Rui Lu Pi-Ling Chang George Luo Herb Chen Andrey Maksimenko Igor Chesnokov Upender Manne Gagandeep Choudhary Andrew McDonald James Cimino Braden McFarland Tatjana Coric Ryan Miller Michael Crowley Kasturi Mitra Pran Datta Amitkumar Mitra Stijn DeLanghe Anthony Morlandt Wendy Demark-Wahnefried Lisle Nabell Jessy Deshane Burt Nabors Girish Dhal Lakshmin Nandagopal Micky Edmonds Soumya Niranjan Ronit Elk Lyse Norian Charles Elson Akin Ojesina Isao Eto Robert Oster Christian Faul Selvarangan Ponnazhagan Jed Ferguson Jeevan Prasain Jeremy Foote Soroush Rais-Bahrami Radhika Gangaraju Bin Ren Barbara Gower Robert Reynolds Romi Gupta Joshua Richman Shuko Harada Gabrielle Rocque Karin Hardiman Brandon Rocque Eason Hildreth Bart Rose Anita Hjelmeland Ralph Sanderson Teri Hoenemeyer Isabel Scarinci Kejin Hu Yu-Mei Schoenberger Douglas Hurst James Shikany Renata Jaskula-Sztul Sadeep Shrestha Amjad Javed Purnima Singh Tamas Jilling Andrzej Slominski 3 Research Competition Judges, Continued Andrew Smith John Waterbor Bruce Smith Shi Wei Anna Sorace Robert Welner Joshua Stern Grant Williams Sunil Sudarshan Scott Wilson Jianming Tang Julie Wolfson Trygve Tollefsbol Elizabeth Worthey Kristen Triebel Gerstenecker Fan Yang Eric Ubil Yang Yang Soory Varambally George Yang Praveen Vayalil Eddy Yang Deeann Wallis Allan Zajac Lizhong Wang Jianhua Zhang Jason Warram Xinyang Zhao 4 Featured Exhibitor 5 Program Agenda - Friday, October 11, 2019 7:30 – 8:00 am Continental Breakfast 8:00 – 8:05 am Ravi Bhatia, M.D. Opening Remarks 8:10 – 8:55 am Dmitry Gabrilovich, M.D., Ph.D., Keynote Speaker Regulation of Immune Response and Tumor Progression by Myeloid- derived Suppressor Cells. 9:00 – 10:15 am Poster Session 1 10:20 – 10:40 am Benjamin Larimer, Ph.D. Predicting Response to Immunotherapy Using Granzyme B PET Imaging 10:45 – 11:30 am David Solit, M.D., Keynote Speaker Defining the Actionable Genome 11:35 – 11:55 am Narendra Wajapeyee, Ph.D. Unbiased Proteomics Approaches for Deciphering Dysregulated Oncogenic Signaling Pathways 12:00 – 1:25 pm Poster Session 2 and Lunch 1:25 – 1:30 pm Presentation of Albert F. LoBuglio Distinguished Faculty Award 1:30 – 1:50 pm Lewis Shi, M.D., Ph.D. Drivers in Cancer Immunotherapy 2:00 – 2:20 pm Ryan Miller, M.D., Ph.D. Probing the Glioblastoma Kinome 2:25 – 3:10 pm Stephen Schoenberger, Ph.D., Keynote Speaker Going Natural with Neoantigens 3:15 – 3:35 pm Elizabeth Worthey, Ph.D. Application of Omic-Based Data Science to Extract Clinically Relevant Information from Relatively Big Data 3:40 – 4:00 pm Brittany Lasseigne, Ph.D. Genome-Guided Cancer Signatures 4:05 – 4:20 pm Presentation of Awards and Closing Remarks 4:20 – 4:40 pm Award Winner photographs 6 Keynote Speaker Dmitry Gabrilovich, M.D., Ph.D. Dmitry Gabrilovich, M.D., Ph.D., is currently a Christopher M. Davis Professor in Cancer Research and Program Leader, Immunology, Microenvironment, and Metastasis at the Wistar Institute in Philadelphia. He is the Wistar Professor at the Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania. Dr. Gabrilovich studied dendritic cell (DC) biology under Dr. Stella C. Knight at the Imperial College of London and then trained in cancer research at U.T. Southwestern Medical School and Vanderbilt University in the laboratory of Dr. D. Carbone. In the mid-1990s, his group demonstrated that DCs in cancer were functionally impaired. They described the first tumor-derived factor directly implicated in DC defects in cancer and suggested that myeloid progenitor cells were the main targets for this negative effect. His group implicated lipid accumulation as one of the mechanisms negatively regulating function of DCs in cancer. Dr. Gabrilovich was one of the discoverers of cells that are now called myeloid- derived suppressor cells (MDSCs). His group characterized a number of molecular mechanisms regulating expansion and function of these cells and that MDSC can be therapeutically targeted in patients. Dr. Gabrilovich was involved in a number of clinical trials testing the effect of cancer vaccines, small molecules and antibodies that target myeloid cells. 7 Keynote Speaker David Solit, M.D., David Solit, MD is a graduate of the University of Pennsylvania School of Medicine and completed a residency in Internal Medicine at Barnes-Jewish Hospital/Washington University in St. Louis. He is a practicing Medical Oncologist and a Laboratory Scientist and the Geoffrey Beene Chair for Cancer Research at Memorial Sloan-Kettering Cancer Center. As a member of the Genitourinary Oncology Service, he specializes in the treatment of prostate and bladder cancers. Dr. Solit is very involved in clinical trials, particularly trials of targeted drugs known as kinase inhibitors. These drugs block pathways inside cancer cells that cause the cells to grow or spread. Dr. Solit has had a long-standing interest in the development of selective inhibitors of the MAP kinase pathway, and his laboratory was a leader in defining mechanisms of resistance to RAF and MEK inhibitors. One long-standing problem in oncology is the variability among patients with the same cancer type to standard and investigational treatments. Dr. Solit has pioneered the use of whole genome sequencing methods to identify occult predictors of drug response, work that serves as the basis for the NCI Extraordinary Responder Initiative. As the Director of the Marie- Josée and Henry R. Kravis Center for Molecular Oncology, Dr. Solit leads a multidisciplinary team of clinicians, geneticists, bioinformaticians and laboratory scientists whose mission is to integrate molecular and clinical information to develop therapies that are individualized to each patient’s cancer. The Kravis Center for Molecular Oncology has led efforts to profile all patients with recurrent or metastatic cancer treated at MSK. Using the MSK-IMPACT targeted assay, MSK has prospectively sequenced over 23,000 patient tumors over the past 3 years. 8 Keynote Speaker Stephen Schoenberger, Ph.D. Dr. Schoenberger joined La Jolla Institute for Immunology in 1998 as an Assistant Professor in the Division of Immune Regulation. In 2002, Dr. Schoenberger became an Associate Professor in the Division of Cellular Immunology, and in 2005 gained Tenure. In 2008, he was promoted to Professor. Dr. Schoenberger’s research focuses on the regulation of cellular immune responses. Dr. Schoenberger received his B.S. from the University of California, Los Angeles in 1987 and his Ph.D. from the same university in 1992. In 1993, Dr. Schoenberger